Stockreport

Visiongain Launches Report Examining the Potential in the $118bn Translational Regenerative Medicine Market

Celyad Oncology SA - American Depositary Shares  (CYAD) 
US:NASDAQ Investor Relations: celyad.com/en/investors
PDF LONDON, March 6, 2020 /PRNewswire/ -- The Global Translational Regenerative Medicine market is estimated to grow at a CAGR of 24% in the first half of the forecast perio [Read more]